Back to
Woodline Partners LP
SNDXShowing 8 of 21 quarters
Position history for
Woodline Partners LP's holdings in SYNDAX PHARMACEUTICALS INC
Woodline Partners LP holds 1.3M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $27.3M as of 2026-Q2. SNDX represents 0.1% of Woodline Partners LP's portfolio.
Current Value
$27.3M
Current Shares
1.3M
Total Value Change
-$9.2M
Total Shares Change
-645,272
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.